Home Cart Sign in  
Chemical Structure| 1765-93-1 Chemical Structure| 1765-93-1

Structure of 4-Fluorobenzeneboronic acid
CAS No.: 1765-93-1

Chemical Structure| 1765-93-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Synonyms: P-Fluorophenylboronic acid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1765-93-1 ]

CAS No. :1765-93-1
Formula : C6H6BFO2
M.W : 139.92
SMILES Code : C1=C(C=CC(=C1)F)B(O)O
Synonyms :
P-Fluorophenylboronic acid
MDL No. :MFCD00039136
InChI Key :LBUNNMJLXWQQBY-UHFFFAOYSA-N
Pubchem ID :285645

Safety of [ 1765-93-1 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 1765-93-1 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 1
Num. H-bond acceptors 3.0
Num. H-bond donors 2.0
Molar Refractivity 36.23
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

40.46 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.0
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.93
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-0.07
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.7
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.3
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.25

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.67
Solubility 2.98 mg/ml ; 0.0213 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.37
Solubility 6.03 mg/ml ; 0.0431 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.54
Solubility 4.04 mg/ml ; 0.0288 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

Yes
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.49 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.82

Application In Synthesis of [ 1765-93-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1765-93-1 ]
  • Downstream synthetic route of [ 1765-93-1 ]

[ 1765-93-1 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 1765-93-1 ]
  • [ 446-52-6 ]
  • [ 342-25-6 ]
YieldReaction ConditionsOperation in experiment
98% With potassium phosphate; palladium diacetate In water; methyl cyclohexane for 8 h; Reflux Method of the present embodiment provides a 2,4 ′-difluorobenzophenone and preparation method thereof, as follows: in a 1000 ml round bottom flask The bottle was added sequentially o-fluoro benzaldehyde 124 g of 4-fluorophenylboronic acid and 140 g of potassium phosphate, 106 grams, 1.12 g of palladium acetate, then adding 500 ml of methyl cyclohexane and 100 ml of water and heated to reflux for 8 hours., sequentially passes through filtering, layering, washing with water, removing the solvent to obtain the product., 2,4 '-difluorobenzophenone 214 g, 98percent yield.
References: [1] Patent: CN104230691, 2016, B, . Location in patent: Paragraph 0028-0029.
  • 2
  • [ 30766-11-1 ]
  • [ 1765-93-1 ]
  • [ 845826-99-5 ]
YieldReaction ConditionsOperation in experiment
87.7% With tetrakis(triphenylphosphine) palladium(0); potassium carbonate In 1,2-dimethoxyethane; water at 98℃; for 24 h; Inert atmosphere Step A:5-bromopyridine-2-carboxylic acid (57, 1.0 g, 5.0 mmol)Dissolved in ethylene glycol dimethyl ether (12 mL) and water (4 mL),Add p-fluorophenylboronic acid (17, 1.0 g, 7.5 mmol)And anhydrous potassium carbonate (1.0 g, 7.5 mmol),Then tetrakis(triphenylphosphine)palladium (289 mg, 0.25 mmol) was added.The resulting mixture was stirred at 98 ° C for 24 hours under a nitrogen atmosphere.TLC analysis indicated that the reaction was over,The reaction solution was cooled to room temperature.Then add water (40 mL),The pH was adjusted to 2-3 with 6M hydrochloric acid.Filtered, the filter cake is dissolved in dichloromethane,The organic layer was washed with 20 mL of saturated sodium bicarbonate solution.Divide the water layer,The aqueous layer was adjusted to pH 2-3 with a 6M hydrochloric acid solution.Filter the solid,The filter cake is washed with water to neutrality.The filter cake was dried to give compound 61 (942 mg).Yield: 87.7percent.
References: [1] Patent: CN108623532, 2018, A, . Location in patent: Paragraph 0206; 0207; 0208.
[2] Patent: EP1657242, 2006, A1, . Location in patent: Page/Page column 31.
[3] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 4, p. 812 - 819.
[4] Medicinal Chemistry, 2017, vol. 13, # 2, p. 176 - 185.
[5] Medicinal Chemistry Research, 2018, vol. 27, # 2, p. 374 - 387.
 

Historical Records

Technical Information

Categories

Pharmaceutical Intermediates of
[ 1765-93-1 ]

ASLAN-002 Intermediates

Chemical Structure| 158669-26-2

[158669-26-2]

4-Iodo-2-methoxynicotinaldehyde

Related Functional Groups of
[ 1765-93-1 ]

Fluorinated Building Blocks

Chemical Structure| 768-35-4

A180833 [768-35-4]

(3-Fluorophenyl)boronic acid

Similarity: 0.98

Chemical Structure| 1993-03-9

A292057 [1993-03-9]

(2-Fluorophenyl)boronic acid

Similarity: 0.93

Chemical Structure| 144025-03-6

A125233 [144025-03-6]

2,4-Difluorophenylboronic acid

Similarity: 0.91

Chemical Structure| 193353-34-3

A169453 [193353-34-3]

(2,5-Difluorophenyl)boronic acid

Similarity: 0.91

Chemical Structure| 850593-06-5

A531963 [850593-06-5]

(3-Fluoro-5-methylphenyl)boronic acid

Similarity: 0.85

Organoborons

Chemical Structure| 768-35-4

A180833 [768-35-4]

(3-Fluorophenyl)boronic acid

Similarity: 0.98

Chemical Structure| 1993-03-9

A292057 [1993-03-9]

(2-Fluorophenyl)boronic acid

Similarity: 0.93

Chemical Structure| 144025-03-6

A125233 [144025-03-6]

2,4-Difluorophenylboronic acid

Similarity: 0.91

Chemical Structure| 193353-34-3

A169453 [193353-34-3]

(2,5-Difluorophenyl)boronic acid

Similarity: 0.91

Chemical Structure| 850593-06-5

A531963 [850593-06-5]

(3-Fluoro-5-methylphenyl)boronic acid

Similarity: 0.85

Aryls

Chemical Structure| 768-35-4

A180833 [768-35-4]

(3-Fluorophenyl)boronic acid

Similarity: 0.98

Chemical Structure| 1993-03-9

A292057 [1993-03-9]

(2-Fluorophenyl)boronic acid

Similarity: 0.93

Chemical Structure| 144025-03-6

A125233 [144025-03-6]

2,4-Difluorophenylboronic acid

Similarity: 0.91

Chemical Structure| 193353-34-3

A169453 [193353-34-3]

(2,5-Difluorophenyl)boronic acid

Similarity: 0.91

Chemical Structure| 850593-06-5

A531963 [850593-06-5]

(3-Fluoro-5-methylphenyl)boronic acid

Similarity: 0.85